POLYTHERICS
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.
POLYTHERICS
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2001-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.polytherics.com
Total Employee:
11+
Status:
Closed
Contact:
+4402076914928
Email Addresses:
[email protected]
Total Funding:
33.14 M USD
Technology used in webpage:
Domain Not Resolving SPF Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Cloudflare DNS Starfield Technologies Mimecast Salesforce SPF Pardot Mail
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-01-20 | Warwick Effect Polymers | Warwick Effect Polymers acquired by PolyTherics | N/A |
Investors List
Mercia Fund Managers
Mercia Fund Managers investment in Venture Round - PolyTherics
Invesco
Invesco investment in Venture Round - PolyTherics
Imperial Innovations
Imperial Innovations investment in Venture Round - PolyTherics
Capital Fund Management
Capital Fund Management investment in Venture Round - PolyTherics
Imperial Innovations
Imperial Innovations investment in Venture Round - PolyTherics
ProVen VCT
ProVen VCT investment in Venture Round - PolyTherics
Venture Capital Trusts (VCTs)
Venture Capital Trusts (VCTs) investment in Venture Round - PolyTherics
Longbow Capital
Longbow Capital investment in Series C - PolyTherics
The Capital Fund
The Capital Fund investment in Series C - PolyTherics
Imperial Innovations
Imperial Innovations investment in Series C - PolyTherics
Official Site Inspections
http://www.polytherics.com
- Host name: 172.67.131.182
- IP address: 172.67.131.182
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PolyTherics"
PolyTherics and Antitope form Abzena | Abzena
In July 2013, PolyTherics and Antitope merge to form Abzena headquartered in Cambridge, UK. New Company Created to be a Leading Provider of Technologies and Services to Enable โฆSee details»
PolyTherics Company Profile | Management and Employees List
PolyTherics is a privately owned UK company backed by institutional investors including Imperial Innovations (AIM: IVO), Invesco Perpetual, Mercia Fund Management, Advantage Enterprise โฆSee details»
Polytherics - Products, Competitors, Financials, Employees ...
Polytherics, also known as Abzena, is a fully integrated contract development and manufacturing organization (CDMO) and contract research organization (CRO) specializing in the โฆSee details»
Polytherics ltd. - VentureRadar
Products produced using PolyThericsโ technologies are more homogeneous, have better stability, and can be tailored to have an extended half-life in the body. The technologies include โฆSee details»
PolyTherics Limited, An Abzena Company | LinkedIn
PolyTherics Limited, An Abzena Company | 685 followers on LinkedIn. We will be closing our Antitope, PacificGMP, PolyTherics and TCRS social media accounts at the end of July as we โฆSee details»
PolyTherics - Company Profile & Staff Directory - ContactOut
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or โฆSee details»
Abzena Company Profile - Office Locations, Competitors, Revenue โฆ
Abzena (formerly known as PolyTherics) is a contract manufacturing organization that develops biopharmaceuticals. It specializes in antibody discovery, design, and engineering, formulation โฆSee details»
PolyTherics - Overview, News & Similar companies - ZoomInfo
Who is PolyTherics. PolyTherics provides technology solutions to enable the development of better biopharmaceuticals and offers a portfolio of proprietary and compleme ntary โฆSee details»
PolyTherics, Ltd. - London, United Kingdom - bionity.com
Jun 3, 2014 PolyTherics has developed and patented an innovative approach to PEGylation, known as TheraPEG(TM), to prolong the half-life of proteins for development as โฆSee details»
PolyTherics | VentureRadar
Find out more about PolyTherics including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps and Links. Homepage โฆSee details»
Abzena's History | Abzena Timeline | Better Biologics
Abzena was established in 2013 when two companies, PolyTherics and Antitope, were combined to create a single leading provider of technologies and services to enable better โฆSee details»
PolyTherics Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
The next five portfolio companies: PolyTherics, PsiOxus Therapeutics, Oxford Immunotec, Cortexica and Cell Medica also continued to develop well. Technology Transfer Office (TTO) โฆSee details»
Polytherics - Company Profile - Tracxn
Oct 20, 2024 Polytherics - Developer of biomedical polymers for biopharmaceutical applications. Raised a total funding of $12.6M over 5 rounds from 6 investors. Polytherics has 146 โฆSee details»
PolyTherics - Funding, Financials, Valuation & Investors - Crunchbase
PolyTherics has acquired Warwick Effect Polymers on Jan 20, 2012. Unlock for free . Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 5. ... How much funding โฆSee details»
PolyTherics | EquityNet
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or โฆSee details»
PolyTherics - Contacts, Employees, Board Members, Advisors
PolyTherics provides a range of technologies and services to develop biomedical polymers for therapeutic applications.See details»
Better pharmaceuticals developed through UCL spinout company ...
Dec 14, 2014 PolyTherics then merged with Antitope Ltd. in July 2013 and the combined company became Abzena in May 2014. Abzena has a suite of services and technologies to โฆSee details»
PolyTherics Ltd. (PolyTherics Ltd.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่ โฆ
The next five portfolio companies: PolyTherics, PsiOxus Therapeutics, Oxford Immunotec, Cortexica and Cell Medica also continued to develop well. Technology Transfer Office (TTO) โฆSee details»
Abzena recognized as Best Novel Treatment Development Partner โฆ
Abzena was established in 2013, following the merger of two industry-leading companies, PolyTherics and Antitope. Both UK-based companies, PolyTherics was considered a pioneer โฆSee details»